SCNI
Price
$2.98
Change
-$0.08 (-2.61%)
Updated
Nov 14 closing price
WINT
Price
$0.49
Change
-$0.04 (-7.55%)
Updated
Nov 14 closing price
Ad is loading...

SCNI vs WINT

Header iconSCNI vs WINT Comparison
Open Charts SCNI vs WINTBanner chart's image
Scinai Immunotherapeutics
Price$2.98
Change-$0.08 (-2.61%)
Volume$6.29K
CapitalizationN/A
Windtree Therapeutics
Price$0.49
Change-$0.04 (-7.55%)
Volume$412.84K
CapitalizationN/A
SCNI vs WINT Comparison Chart
Loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SCNI vs. WINT commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCNI is a Sell and WINT is a StrongSell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (SCNI: $2.98 vs. WINT: $0.49)
Brand notoriety: SCNI and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCNI: 20% vs. WINT: 22%
Market capitalization -- SCNI: $2.54M vs. WINT: $4.33M
SCNI [@Biotechnology] is valued at $2.54M. WINT’s [@Biotechnology] market capitalization is $4.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCNI’s FA Score shows that 1 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • SCNI’s FA Score: 1 green, 4 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than SCNI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCNI’s TA Score shows that 3 TA indicator(s) are bullish while WINT’s TA Score has 2 bullish TA indicator(s).

  • SCNI’s TA Score: 3 bullish, 4 bearish.
  • WINT’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both SCNI and WINT are a bad buy in the short-term.

Price Growth

SCNI (@Biotechnology) experienced а -14.86% price change this week, while WINT (@Biotechnology) price change was -18.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

SCNI is expected to report earnings on May 02, 2023.

WINT is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WINT($4.33M) has a higher market cap than SCNI($2.54M). SCNI YTD gains are higher at: -49.950 vs. WINT (-96.177). SCNI has more cash in the bank: 17.4M vs. WINT (917K). WINT has less debt than SCNI: WINT (1.48M) vs SCNI (20.6M).
SCNIWINTSCNI / WINT
Capitalization2.54M4.33M59%
EBITDAN/AN/A-
Gain YTD-49.950-96.17752%
P/E RatioN/A0.83-
RevenueN/AN/A-
Total Cash17.4M917K1,897%
Total Debt20.6M1.48M1,388%
FUNDAMENTALS RATINGS
SCNI vs WINT: Fundamental Ratings
SCNI
WINT
OUTLOOK RATING
1..100
7780
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8898
P/E GROWTH RATING
1..100
947
SEASONALITY SCORE
1..100
24n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (33) in the Pharmaceuticals Major industry is in the same range as WINT (62) in the Biotechnology industry. This means that SCNI’s stock grew similarly to WINT’s over the last 12 months.

SCNI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as WINT (100) in the Biotechnology industry. This means that SCNI’s stock grew similarly to WINT’s over the last 12 months.

WINT's SMR Rating (99) in the Biotechnology industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that WINT’s stock grew similarly to SCNI’s over the last 12 months.

SCNI's Price Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as WINT (98) in the Biotechnology industry. This means that SCNI’s stock grew similarly to WINT’s over the last 12 months.

WINT's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for SCNI (94) in the Pharmaceuticals Major industry. This means that WINT’s stock grew significantly faster than SCNI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCNIWINT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with PIRS. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-2.61%
PIRS - SCNI
91%
Closely correlated
-0.93%
WINT - SCNI
89%
Closely correlated
-6.25%
NBY - SCNI
88%
Closely correlated
+2.04%
NCNA - SCNI
88%
Closely correlated
-1.90%
SNPX - SCNI
88%
Closely correlated
-4.68%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been closely correlated with PIRS. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if WINT jumps, then PIRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
-6.25%
PIRS - WINT
94%
Closely correlated
-0.93%
CDTX - WINT
94%
Closely correlated
+4.17%
NCNA - WINT
92%
Closely correlated
-1.90%
SNPX - WINT
92%
Closely correlated
-4.68%
NBY - WINT
92%
Closely correlated
+2.04%
More